The Crohn's & Colitis Foundation is the leading non-profit organization focused on both research and patient support for inflammatory bowel disease (IBD). The Foundation’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life for the millions of Americans living with IBD. Our work is dramatically accelerating the research process through our database and investment initiatives; we also provide extensive educational resources for patients and their families, medical professionals, and the public.
View Top Employees from Crohn's & Colitis FoundationWebsite | http://www.crohnscolitisfoundation.org/ |
Revenue | $81 million |
Funding | $7 million |
Employees | 557 (526 on RocketReach) |
Founded | 1967 |
Address | 733 3rd Ave Suite 510, New York, New York, US |
Phone | (212) 685-3440 |
Fax | (212) 779-4098 |
Technologies |
JavaScript,
HTML,
PHP
+47 more
(view full list)
|
Category | Consumer Services, Non-profit Organizations, Team Challenge Half Marathon Training Program, Take Steps Walk Program |
Web Rank | 224073 |
Web Visits | 276160 |
Keywords | crohn's disease, ulcerative colitis, crohn's and colitis foundation, crohns disease, enfermedad de crohn, what is irritable bowel syndrome, ccfa, inflammatory bowel disease, diet for people with inflammatory bowel disease |
Competitors | ALS Society of BC, American Liver Foundation, Arthritis Foundation, National Kidney Foundation of Florida, The Leukemia & Lymphoma Society |
SIC | 839, 83 |
NAICS | 81321, 81, 813, 813212, 8132 |
Looking for a particular Crohn's & Colitis Foundation employee's phone or email?
The Crohn's & Colitis Foundation annual revenue was $81 million in 2023.
Judy Hoffstein is the Chief Marketing and Communications Officer of Crohn's & Colitis Foundation.
526 people are employed at Crohn's & Colitis Foundation.
Crohn's & Colitis Foundation is based in New York, New York.
The NAICS codes for Crohn's & Colitis Foundation are [81321, 81, 813, 813212, 8132].
The SIC codes for Crohn's & Colitis Foundation are [839, 83].